Key Dates For Coming Week
SalvaRx Group plc (LON:SALV) Suspension of Trading
SalvaRx announces that trading in the Company’s ordinary shares on AIM will be suspended with effect from 7.30 a.m. today.
SALVARX GROUP PLC (LON:SALV) Result of AGM and Completion of Disposal and Demerger
SalvaRx (AIM: SALV), the drug discovery and development company focused on cancer immunotherapy, is pleased to announce that at its Annual General Meeting held earlier today all resolutions set out
The AIM wonder stocks of 2018
“High risk, high reward” just about sums up investing on AIM
Share Talk Bulletin Board Heroes, Tuesday 18th December 2018
A charting look at some of the most followed stocks on the London market, Zak Mir covers.
Share Talk Bulletin Board Heroes, Wednesday 12th December 2018
A charting look at some of the most followed stocks on the London market, Zak Mir covers.
Share Talk Bulletin Board Heroes: Tuesday, 23rd October 2018
A charting look at some of the most followed stocks on the London market, Zak Mir covers.
Share Talk Bulletin Board Heroes: 5th Sep 2018
A charting look at some of the most followed stocks on the London market, Zak Mir covers.
Share Talk Bulletin Board Heroes: 14th Aug 2018
A charting look at some of the most followed stocks on the London market, Zak Mir covers.
SalvaRx Group plc (AIM:SALV) Proposed disposal of interest in SalvaRx Limited
SalvaRx Group plc (AIM: SALV), a biotechnology company focused on discovering and developing immunotherapies for cancer, announces that it has entered into a conditional sale agreement (the “Sale Agreement”)